ASSESSING IMPACTS OF MAJOR DEPRESSIVE DISORDER (MDD) ON COGNITIVE FUNCTION

Author(s)

Forsyth B1, Fehnel SE2, Danchenko N3, François C4, Brevig T51RTI-Health Solutions, rockville, MD, USA, 2RTI Health Solutions, Research Triangle Park, NC, USA, 3Lundbeck S.A.S., issey-les- moulineaux, France, 4Lundbeck S.A.S., Issy-les-Moulineaux , France, 5Lundbeck S.A.S., issy-les-moulineaux, France

OBJECTIVES: 1) to identify concepts relevant to patients when  measuring cognitive symptoms of depression and their impacts, and 2) to adapt an existing patient-reported measure of cognitive function for MDD. METHODS: Four age-stratified focus groups (total N = 33) were conducted with adults under treatment for MDD. Following open concept elicitation, participants provided feedback on two self-report measures of cognitive symptoms: the Applied Cognition General Concerns Scale (Gerson et al., 2006) and the Perceived Deficits Questionnaire (PDQ) (Sullivan et al., 1990). Focus group results led to a modified PDQ for MDD. Two sets of cognitive interviews with additional MDD patients (N = 17) refined the instrument, resulting in the PDQ for Depression (PDQ-D). RESULTS: Focus group participants reported seven different categories of cognitive symptoms.  Across the age strata, the most bothersome were difficulties with concentration, attention and memory. Patients described many ways their cognitive symptoms affected them; productivity limitations were among the most salient.  While most focus group participants deemed the PDQ content appropriate, a shorter reference period and more explicit response options were suggested. Cognitive interview results suggested that the initial version of the 20-item PDQ-D was an appropriate and comprehensive assessment of cognitive symptoms of MDD. Interview participants found the items easy to understand and answer. Minor modifications made in early interviews facilitated completion of the measure in later interviews. CONCLUSIONS: The PDQ-D is a patient-reported assessment of cognitive function with potential to provide unique information important for comprehensive evaluation of individual patients with MDD and new treatments for this disorder.

Conference/Value in Health Info

2012-11, ISPOR Europe 2012, Berlin, Germany

Value in Health, Vol. 15, No. 7 (November 2012)

Code

PMH42

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×